Acupuncture therapy for vasomotor symptoms in breast cancer: Protocol for a prospective, multicenter, case registry study

IF 1.9 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE
Jia-Shan Li , Zi-Yan Li , Xing-Fang Pan , Zhuo-Xin Yang , Jia Liu , Xin Wang , Hong-Jiao Li , Lin Luo , Bo Chen , Bao-Yan Liu , Yi Guo , Li-Yun He , Tian-Yi Zhao
{"title":"Acupuncture therapy for vasomotor symptoms in breast cancer: Protocol for a prospective, multicenter, case registry study","authors":"Jia-Shan Li ,&nbsp;Zi-Yan Li ,&nbsp;Xing-Fang Pan ,&nbsp;Zhuo-Xin Yang ,&nbsp;Jia Liu ,&nbsp;Xin Wang ,&nbsp;Hong-Jiao Li ,&nbsp;Lin Luo ,&nbsp;Bo Chen ,&nbsp;Bao-Yan Liu ,&nbsp;Yi Guo ,&nbsp;Li-Yun He ,&nbsp;Tian-Yi Zhao","doi":"10.1016/j.eujim.2025.102429","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Adjuvant endocrine therapy for breast cancer has advantages such as reducing the incidence of recurrence. However, adjuvant endocrine therapy may cause adverse vasomotor symptoms. Although randomized controlled trials (RCTs) have shown that acupuncture therapy is an effective treatment for vasomotor symptoms in patients with breast cancer, a practical real-world acupuncture regimen has yet to be established. Therefore, there is an urgent need for a case registry study that provides real-world evidence for the effectiveness of acupuncture therapy in treating vasomotor symptoms. This article presents the protocol for a case registry study that aims to provide an overview of the acupuncture therapy for managing vasomotor symptoms in patients with breast cancer.</div></div><div><h3>Methods</h3><div>The study cohort will comprise patients with breast cancer with vasomotor symptoms who are aged between 18 and 70 years and are undergoing adjuvant endocrine therapy. Patients will be recommended to receive acupuncture therapy, without excluding other treatments. The primary outcome is the patient-reported change in the hot flashes score. Electronic case report forms will be used to record patient demographic characteristics, information about interventions, and information about medical personnel from week 1 to 8, with a subsequent follow-up period of 24 weeks. At least 250 patients will be recruited from six medical hospitals. Adverse events will be monitored and recorded. An appropriate mixed model will be used to analyze the factors potentially influencing the effects of acupuncture therapy.</div></div><div><h3>Discussion</h3><div>This multicenter, prospective, observational, case registry study will bridge the gap between the clinical practices of acupuncture therapy and the evidence established through RCTs and systematic reviews. The findings will provide knowledge to better inform regulatory decision-making.</div></div><div><h3>Conclusion</h3><div>The findings of this case registry study will identify subgroups of patients with breast cancer that will benefit from acupuncture therapy for vasomotor symptoms.</div></div><div><h3>Registration</h3><div>This study was registered in the Chinese Clinical Trial Registry (ChiCTR2400081274)</div></div>","PeriodicalId":11932,"journal":{"name":"European Journal of Integrative Medicine","volume":"74 ","pages":"Article 102429"},"PeriodicalIF":1.9000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Integrative Medicine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1876382025000010","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INTEGRATIVE & COMPLEMENTARY MEDICINE","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction

Adjuvant endocrine therapy for breast cancer has advantages such as reducing the incidence of recurrence. However, adjuvant endocrine therapy may cause adverse vasomotor symptoms. Although randomized controlled trials (RCTs) have shown that acupuncture therapy is an effective treatment for vasomotor symptoms in patients with breast cancer, a practical real-world acupuncture regimen has yet to be established. Therefore, there is an urgent need for a case registry study that provides real-world evidence for the effectiveness of acupuncture therapy in treating vasomotor symptoms. This article presents the protocol for a case registry study that aims to provide an overview of the acupuncture therapy for managing vasomotor symptoms in patients with breast cancer.

Methods

The study cohort will comprise patients with breast cancer with vasomotor symptoms who are aged between 18 and 70 years and are undergoing adjuvant endocrine therapy. Patients will be recommended to receive acupuncture therapy, without excluding other treatments. The primary outcome is the patient-reported change in the hot flashes score. Electronic case report forms will be used to record patient demographic characteristics, information about interventions, and information about medical personnel from week 1 to 8, with a subsequent follow-up period of 24 weeks. At least 250 patients will be recruited from six medical hospitals. Adverse events will be monitored and recorded. An appropriate mixed model will be used to analyze the factors potentially influencing the effects of acupuncture therapy.

Discussion

This multicenter, prospective, observational, case registry study will bridge the gap between the clinical practices of acupuncture therapy and the evidence established through RCTs and systematic reviews. The findings will provide knowledge to better inform regulatory decision-making.

Conclusion

The findings of this case registry study will identify subgroups of patients with breast cancer that will benefit from acupuncture therapy for vasomotor symptoms.

Registration

This study was registered in the Chinese Clinical Trial Registry (ChiCTR2400081274)
求助全文
约1分钟内获得全文 求助全文
来源期刊
European Journal of Integrative Medicine
European Journal of Integrative Medicine INTEGRATIVE & COMPLEMENTARY MEDICINE-
CiteScore
4.70
自引率
4.00%
发文量
102
审稿时长
33 days
期刊介绍: The European Journal of Integrative Medicine (EuJIM) considers manuscripts from a wide range of complementary and integrative health care disciplines, with a particular focus on whole systems approaches, public health, self management and traditional medical systems. The journal strives to connect conventional medicine and evidence based complementary medicine. We encourage submissions reporting research with relevance for integrative clinical practice and interprofessional education. EuJIM aims to be of interest to both conventional and integrative audiences, including healthcare practitioners, researchers, health care organisations, educationalists, and all those who seek objective and critical information on integrative medicine. To achieve this aim EuJIM provides an innovative international and interdisciplinary platform linking researchers and clinicians. The journal focuses primarily on original research articles including systematic reviews, randomized controlled trials, other clinical studies, qualitative, observational and epidemiological studies. In addition we welcome short reviews, opinion articles and contributions relating to health services and policy, health economics and psychology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信